Takeda Pharmaceutical (TAK) Invested Capital: 2017-2025

Historic Invested Capital for Takeda Pharmaceutical (TAK) over the last 9 years, with Mar 2025 value amounting to $75.2 billion.

  • Takeda Pharmaceutical's Invested Capital fell 8.21% to $75.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $75.1 billion, marking a year-over-year decrease of 8.21%. This contributed to the annual value of $75.2 billion for FY2025, which is 10.53% down from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Invested Capital of $75.2 billion as of FY2025, which was down 10.53% from $84.0 billion recorded in FY2024.
  • Over the past 5 years, Takeda Pharmaceutical's Invested Capital peaked at $92.6 billion during FY2021, and registered a low of $75.2 billion during FY2025.
  • Its 3-year average for Invested Capital is $79.6 billion, with a median of $79.5 billion in 2023.
  • Per our database at Business Quant, Takeda Pharmaceutical's Invested Capital decreased by 11.05% in 2023 and then rose by 5.72% in 2024.
  • Takeda Pharmaceutical's Invested Capital (Yearly) stood at $92.6 billion in 2021, then declined by 3.47% to $89.3 billion in 2022, then dropped by 11.05% to $79.5 billion in 2023, then climbed by 5.72% to $84.0 billion in 2024, then fell by 10.53% to $75.2 billion in 2025.